B
Biokinetica | Jozefow, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
CLN-619
Olezarsen
Pembrolizumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 3 total trials
CLN-619-001 is a Phase 1, open-label, multi-center study of CLN-619 alone and in combination with pembrolizumab in patients with advanced solid tumor...
Active, not recruiting
Advanced Solid Tumor
NSCLC
Drug: CLN-619
Drug: Datopotamab deruxtecan-dlnk (Dato-DXd)
Trial sponsors
A
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems